AGP Executive Report
Last update: 7 hours agoRegulation & Safety: Ghana’s Ministry of Health is drafting a National AI Health Policy and Guidelines to set legal, ethical, and operational guardrails for safe AI use, including data protection and workforce readiness. Clinical Innovation: The FDA approved oveporexton (ORZEYFUL), the first oral orexin receptor agonist for the full symptom burden of narcolepsy type 1 in adults, aiming to treat the underlying orexin signaling deficit. Diagnostics & Tech: VoxNeuro received FDA 510(k) clearance for its EEG-based cognitive assessment software as an adjunct to standard testing, not a standalone diagnosis. Women’s Health & Work: A global survey by the Healthcare Businesswomen’s Association found many women lose productivity from women’s health issues, with only a small share feeling supported at work. Access & Community Care: Bangladesh launched “Health Express” to expand ultrasound access in underserved districts via live demos and clinician training. Food Safety: CDC warned of a multistate Salmonella outbreak linked to jalapeños, urging consumers and retailers to discard affected produce. Healthcare Affordability: Arizona erased over $1B in medical debt for residents through a state initiative. Maternal Care: North Carolina recognized three maternity centers for breastfeeding-friendly practices, awarding up to five stars. Fraud Watch: A sleep-study company owner in Oregon pleaded guilty to a $2M healthcare fraud scheme involving improper billing.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.